Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2004-12-3
pubmed:abstractText
The active vitamin D(3) regulates proliferation and differentiation of epidermal keratinocytes. Although topical application of steroid has been principal therapy for psoriasis, there occurs some side effects such as skin atropy, telangiectasis, and purpura. Recently topical vitamin D(3), tacalcitol, calcipotriol, and maxacalcitol, which avoid these side effects, are widely used for psoriasis. In this review, we discussed the mechanism, effect, and side effect of topical vitamin D(3) for psoriasis.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0917-5857
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
129-32
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:15577145-Administration, Topical, pubmed-meshheading:15577145-Cell Differentiation, pubmed-meshheading:15577145-Cell Division, pubmed-meshheading:15577145-Cholecalciferol, pubmed-meshheading:15577145-Combined Modality Therapy, pubmed-meshheading:15577145-Cyclosporine, pubmed-meshheading:15577145-Drug Therapy, Combination, pubmed-meshheading:15577145-Humans, pubmed-meshheading:15577145-Keratinocytes, pubmed-meshheading:15577145-Ointments, pubmed-meshheading:15577145-PUVA Therapy, pubmed-meshheading:15577145-Phosphorylation, pubmed-meshheading:15577145-Protein Precursors, pubmed-meshheading:15577145-Proto-Oncogene Proteins c-myc, pubmed-meshheading:15577145-Psoriasis, pubmed-meshheading:15577145-Receptor, Epidermal Growth Factor, pubmed-meshheading:15577145-Transglutaminases
pubmed:year
2004
pubmed:articleTitle
[Treatment of the keratinizing skin disorder, psoriasis, by topical vitamin D3].
pubmed:affiliation
Department of Dermatology, Asahikawa Medical College.
pubmed:publicationType
Journal Article, English Abstract, Review